Natera · 1 day ago
Medical Science Liaison - Oncology
United States
Full-time
Remote
Mid, Senior Level
$14K/yr - $170K/yrNatera is a global leader in cell-free DNA testing, focusing on oncology, women's health, and organ health. They are seeking a Medical Science Liaison for Oncology to provide scientific support and develop relationships with key opinion leaders in the field, particularly in lung and head & neck cancers.
BiotechnologyGeneticsHealth DiagnosticsMedicalWomen's
Responsibilities
Provide scientific and clinical presentations on Natera’s oncology products, specifically relevant to lung and/or head and neck cancers
Address the specific needs of customers by responding to requests for information about our marketed and developing products across solid tumors
Serve as a medical and scientific resource for the Natera Sales and Marketing teams, including participation in scientific updates and training with emphasis on lung and/or head and neck cancer data as appropriate
Identify, develop, maintain, and manage collaborative working relationships with key academic and community physicians (“KOLs”) in oncology, including thoracic and/or head and neck surgeons, radiation oncology and medical oncology specialists
Develop research collaborations with leading KOLs and assist with registry study enrollment and sourcing/managing investigator-initiated trials (IIT) in solid tumors, focusing on lung and/or head and neck cancer opportunities
Review and develop educational materials and slide content for healthcare providers and patients—incorporating tumor-type–specific scientific context—subject to approval by Medical Affairs and Marketing
Assist in agenda planning and meeting facilitation of Clinical Advisory Boards and Symposia, involving thoracic and/or head and neck oncology experts
This role works with PHI on a regular basis in both paper and electronic form and utilizes various technologies to securely access PHI in order to perform responsibilities
Qualification
Required
Health care professionals with relevant clinical sciences knowledge in oncology will be considered: Pharm.D, Ph.D., M.D., Doctoral-level Nurse Practitioners (DNP)
Prior MSL experience highly preferred; prior involvement with lung and/or head and neck oncology or clinical laboratory tests is also preferred
Outgoing and confident demeanor and independent thinker and persuasive communicator
Experience establishing strong, collaborative working relationships with internal stakeholders (e.g., Sales, Marketing, Regulatory, R&D) and external oncology customers in thoracic and/or head and neck
Ability to work independently and remotely while maintaining a strong teamwork ethic
Outstanding oral presentation skills, particularly when conveying complex scientific concepts related to solid tumors
Preferred
Knowledge of molecular biology and clinical oncology helpful; familiarity with lung and/or head and neck cancer treatment landscapes is a plus
Benefits
Comprehensive medical, dental, vision, life and disability plans for eligible employees and their dependents
Free testing in addition to fertility care benefits
Pregnancy and baby bonding leave
401k benefits
Commuter benefits
Generous employee referral program
Company
Natera
Natera specializes in cell-free DNA testing to provide a more targeted interventions to oncology, women's health, and organ health.
Founded in 2004
5001-10000 employees
H1B Sponsorship
Natera has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (90)
2024 (72)
2023 (37)
2022 (71)
2021 (64)
2020 (40)
Funding
Current Stage
Public CompanyTotal Funding
$1.16BKey Investors
Sofinnova InvestmentsLightspeed Venture PartnersSequoia Capital
2023-09-07Post Ipo Equity· $250M
2022-11-15Post Ipo Equity· $400.05M
2022-03-16Post Ipo Equity· $5M
Leadership Team
Steve Chapman
CEO
Jonathan Sheena
Co-Founder, Board Member
Recent News
2026-01-08
Company data provided by crunchbase